biote Corp. (BTMD)
NASDAQ: BTMD
· Real-Time Price · USD
2.98
-0.11 (-3.56%)
At close: Sep 24, 2025, 3:59 PM
3.01
0.97%
After-hours: Sep 24, 2025, 07:07 PM EDT
biote Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dietary Supplements Revenue | 10.75M | 9.27M | 18.31M | 10.32M | 8.24M | 7.39M | 9.13M | 8.47M | 12.15M | 8.33M | 24.46M | 8.07M | 7.95M |
| Dietary Supplements Revenue Growth | +15.95% | -49.38% | +77.49% | +25.19% | +11.53% | -19.11% | +7.79% | -30.25% | +45.86% | -65.95% | +203.29% | +1.47% | n/a |
| Other Service Revenue Revenue | 535K | 1.31M | 1.35M | 702K | 470K | 221K | 206K | 171K | 178K | 142K | 122.34M | 41.57M | 40.79M |
| Other Service Revenue Revenue Growth | -59.04% | -2.97% | +91.74% | +49.36% | +112.67% | +7.28% | +20.47% | -3.93% | +25.35% | -99.88% | +194.28% | +1.92% | n/a |
| Product Revenue Revenue | 47.66M | 47.02M | 96.4M | 49.81M | 48.11M | 46.03M | 44.94M | 44.83M | 48.65M | 44.16M | 1.25M | 396K | 570K |
| Product Revenue Revenue Growth | +1.34% | -51.22% | +93.55% | +3.52% | +4.51% | +2.45% | +0.23% | -7.85% | +10.18% | +3421.13% | +216.67% | -30.53% | n/a |
| Service Revenue Revenue | 1.21M | 1.97M | 2.6M | 1.58M | 1.06M | 769K | 768K | 726K | 605K | 688K | 617K | 186K | 356K |
| Service Revenue Revenue Growth | -38.69% | -24.46% | +65.02% | +49.15% | +37.58% | +0.13% | +5.79% | +20.00% | -12.06% | +11.51% | +231.72% | -47.75% | n/a |
| Training Service Revenue Revenue | 333K | 326K | 609K | 573K | 298K | 274K | 983K | 321K | 202K | -336K | n/a | n/a | n/a |
| Training Service Revenue Revenue Growth | +2.15% | -46.47% | +6.28% | +92.28% | +8.76% | -72.13% | +206.23% | +58.91% | -160.12% | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States Revenue | 48.6M | 48.7M | 100.55M | 49.99M | 47.57M | 379K | 206K | 261K | 97K | 171K | 281K | 116K | 110K |
| United States Revenue Growth | -0.21% | -51.57% | +101.14% | +5.09% | +12450.92% | +83.98% | -21.07% | +169.07% | -43.27% | -39.15% | +142.24% | +5.45% | n/a |
| All Other Country Revenue | 252K | 246K | 825K | -185K | 543K | 45.66M | 43.44M | 44.57M | 49.16M | 44.67M | 121.49M | 41.85M | 41.25M |
| All Other Country Revenue Growth | +2.44% | -70.18% | -545.95% | -134.07% | -98.81% | +5.11% | -2.54% | -9.34% | +10.05% | -63.23% | +190.28% | +1.47% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 24.22M | 26.69M | 32.76M | 24.03M | 27.65M | 22.26M | 20.12M | 23.79M | 25.76M | 23.09M | 21.57M | 20.61M | 113.06M | 14.89M | 17.64M | 13.73M | 12.39M | 10.79M | 9.5M |
| Selling, General, and Administrative Revenue Growth | -9.25% | -18.53% | +36.35% | -13.10% | +24.21% | +10.64% | -15.43% | -7.64% | +11.59% | +7.01% | +4.67% | -81.77% | +659.47% | -15.59% | +28.47% | +10.83% | +14.80% | +13.58% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |